Lexicon Pharmaceuticals | Umlaufvermögen





Umlaufvermögen Veränderung Datum
Abbott USD 24.84B 371M 2025-09
Acadia Pharmaceuticals USD 1.08B 115.87M 2025-09
Agios Pharmaceuticals USD 1.03B 13.64M 2025-09
Akebia Therapeutics USD 258.34M 23.68M 2025-09
Alnylam Pharmaceuticals USD 3.95B 309.11M 2025-09
AstraZeneca USD 28.72B 1.22B 2025-12
BioMarin Pharmaceutical USD 3.85B 49.21M 2025-09
Coherus Biosciences USD 460.96M 80.75M 2025-09
Eli Lilly USD 62.07B 12.22B 2025-09
Esperion Therapeutics USD 360.46M 17.87M 2025-09
Halozyme Therapeutics USD 1.33B 206.08M 2025-09
Illumina USD 3.29B 493M 2025-12
Insmed USD 1.93B 149.77M 2025-09
Ironwood Pharmaceuticals USD 273.84M 82.09M 2025-09
J&J USD 54.61B 113M 2025-09
Lexicon Pharmaceuticals USD 145.08M 100.72M 2025-06
MacroGenics USD 232.09M 27.15M 2025-09
MannKind USD 358.84M 79.81M 2025-09
Merck USD 47.56B 10.49B 2025-09
Moderna USD 6.6B 427M 2025-09
Novartis USD 28.2B 2.26B 2025-09
PTC Therapeutics USD 2.01B 265.07M 2025-09
Puma Biotechnology USD 143.58M 7M 2025-09
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
Thermo Fisher Scientific USD 28.71B 6.41B 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
United Therapeutics USD 3.49B 332.9M 2025-09
Vanda Pharmaceuticals USD 367.5M 27.42M 2025-09


Lexicon Pharmaceuticals Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.